Overview Technology Investors Clinical Trials Careers News Contact Us Home
 

Press

Articles:

Marcus, Amy Dockser, 2004 April 20. Link Between Cancer, Birth Defects. The Wall Street Journal. Page D1

Shah, PhD, Anjani, 2004. The Pitch, Lab to Wall Street, Volume 2:7.

MB, 2003. Rare Opportunity, Acumen Journal of Life Sciences Volume I, Number III Page 12

Dvorin, Nancy, 05/01/2004. Start-Up: Windhover's Review of Emerging Medical Ventures, Start-Ups Across Health Care (Short Article) Emerging Company Profile, page 42.


Press Releases:
04/16/08NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks named President-elect of AACR
02/22/08NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
11/01/07NexGenix Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
09/26/07NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
07/13/07NexGenix Pharmaceuticals Closes $3.9M Round of Financing
10/24/06NexGenix Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare Conference
09/25/06NexGenix Pharmaceuticals Announces Key Personnel Appointments as it Prepares to Enter Clinical Trials in the US
05/23/06NexGenix Pharmaceuticals to Present at BIO VentureForum East 2006
01/31/06NexGenix Pharmaceuticals Announces New Appointments
12/06/05NexGenix Pharmaceuticals Scientific Advisor / Founder Jacks Awarded Prize for Cancer Research by Memorial Sloan Kettering Cancer Center
San Diego Businessman Douglas F. (Papa Doug) Manchester Elected to Nexgenix Board of Directors
09/29/05NexGenix Pharmaceuticals to Present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference
07/26/04NexGenix Pharmaceuticals Announces New Appointments
04/20/04NexGenix Pharmaceuticals Appoints Dr. Laura Philips as COO; Wall Street Journal Article Mentions Company
10/24/03NexGenix Pharmaceuticals Announces Breakthrough in NF2 Research
07/21/03 NexGenix Pharmaceuticals Begins Operations

Back to top button